Study shows tofacitinib medication can fix porousness absconds in the digestive tract Kumar Jeetendra | October 6, 2020 A team of researchers led by biomedical scientist Declan F. McCole in the University of California, Riverside, has found that the medication tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can fix permeability defects in the intestine. Study results appear in the Journal of Crohn’s and Colitis. …
Analysts expect to recognize illness resistance instruments in sepsis patients Kumar Jeetendra | October 16, 2020 Sepsis is estimated to cause 11 million deaths each year in the world. Its treatment is based on the use of antibiotics and organ support measures, but many times it fails because of unsuccessful attempts at controlling the immune reaction. Surviving a serious infection requires the activation of mechanisms both of resistance. This reduce the …
Trial ALS drug shows potential to drag out patient endurance Kumar Jeetendra | October 18, 2020 An experimental medicine that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the capacity to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts …
Researchers devise new technique to plan HIV’s sweet shield in remarkable detail Kumar Jeetendra | October 26, 2020 Scientists from Scripps Research and Los Alamos National Laboratory have devised a method for mapping in unprecedented detail the thickets of slippery sugar molecules which help protect HIV from the immune system. Mapping these shields will give researchers a more comprehensive comprehension of why dinosaurs respond to some spots on the virus but not others, …
Study recognizes 17 new genes that could be focused for treatment of psoriasis, dermatitis Kumar Jeetendra | October 27, 2020 A Swedish study has identified 17 new genes which could be targeted for therapy of psoriasis and eczema, two frequent hereditary skin diseases with no cure. Pelin Sahlén, senior lecturer in KTH Royal Institute of Technology, says the joint KTH-Karolinska Institutet research team mapped 118 gene targets regarding the skin ailments, psoriasis and atopic dermatitis, …
Myeloid cells can smother insusceptible reaction, advance cerebrum metastasis Kumar Jeetendra | October 28, 2020 Scientists have long thought that the brain protects itself from an aggressive immune response to keep inflammation down. However, that evolutionary management may work against it when a cancer cell tries to spread to the brain, researchers at the University of Notre Dame have found. In recently published research in the journal Cell, researchers showed …
Cell scientists and bioimaging master collaborate to settle fourth measurement insider facts Kumar Jeetendra | October 29, 2020 Cell biologists at the University of Illinois in Urbana-Champaign and Bar-Ilan University in Israel and a bioimaging expert at the University of Central Florida are teaming up in what they expect may result in a major breakthrough in the understanding of the three-dimensional organization of the nucleus over their role in certain diseases. The dream …
SARS-CoV-2 hereditary changes may have made COVID-19 more infectious Kumar Jeetendra | October 31, 2020 A study involving over 5,000 COVID-19 patients in Houston finds the virus which causes the disease is accumulating genetic mutations, one of which may have made it longer infectious. According to the paper published in the peer reviewed journal mBIO, that mutation, known as D614G, is found in the spike protein that pries open our …
Engineered counter acting agent may forestall Covid from contaminating human cells Kumar Jeetendra | November 4, 2020 By screening hundreds of artificial antibodies, researchers at Karolinska Institutet in Sweden and EMBL Hamburg in Germany have identified an antibody that may prevent the new coronavirus from infecting human cells. The analysis, which is printed in the journal Nature Communications, also reveals how electrons can be quickly generated in the event of future pandemics. …
Researchers use quality treatment to recover harmed optic nerve filaments Kumar Jeetendra | November 5, 2020 Scientists have used gene therapy to regenerate damaged nerve fibers from the eye, in a discovery that could aid the development of new treatments for glaucoma, one of the main causes of blindness worldwide. Axons – nerve pathways – in the adult central nervous system (CNS) do not normally regenerate after injury and disease, meaning …
Bacteria use signaling particles to adjust their way of life to winning everyday environments Kumar Jeetendra | November 16, 2020 Bacteria are considered to be true experts in survival. Their rapid adaptive response to changing environmental conditions is based, among other things, on two rival signaling molecules. As the”Yin and Yang” of metabolic control they choose the lifestyle of bacteria, according to researchers in the University of Basel. The findings also play a role in …
Biocompatible photooxygenation catalyst could be conceivably used to treat amyloid infections Kumar Jeetendra | November 26, 2020 The catalyst was able to oxygenate Aβ embedded beneath the skin of a living mouse, and diminished intact Aβ degree in AD-model mouse brain. The new catalyst is potentially useful for the treatment of peripheral amyloid diseases and AD. Toxic aggregation of amyloid peptide and protein is closely associated with a number of human diseases. …
